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Abstract
In recent years, illness and death due to chronic disease 
in the US Associated Pacific Islands (USAPI) jurisdictions 
have dramatically increased. Effective chronic disease sur-
veillance can help monitor disease trends, evaluate public 
policy, prioritize resource allocation, and guide program 
planning,  evaluation,  and  research.  Although  chronic 
disease  surveillance  is  being  conducted  in  the  USAPI, 
no  recently  published  capacity  assessments  for  chronic 
disease  surveillance  are  available.  The  objective  of  this 
study was to assess the quality of existing USAPI chronic 
disease data sources and identify jurisdictional capacity 
for chronic disease surveillance. The assessment included 
a chronic disease data source inventory, literature review, 
and review of surveillance documentation available from 
the web or through individual jurisdictions. We used the 
World  Health  Organization’s  Health  Metric  Network 
Framework  to  assess  data  source  quality  and  to  iden-
tify  jurisdictional  capacity.  Results  showed  that  USAPI 
data sources are generally aligned with widely accepted 
chronic  disease  surveillance  indicators  and  use  stan-
dardized data collection methodology to measure chronic 
disease  behavioral  risks,  preventive  practices,  illness, 
and death. However, all jurisdictions need to strengthen 
chronic  disease  surveillance  through  continued  assess-
ment and expanded support for valid and reliable data 
collection,  analysis  and  reporting,  dissemination,  and 
integration among population-based and institution-based 
data  sources.  For  sustained  improvement,  we  recom-
mend  investment  and  technical  assistance  in  support 
of a chronic disease surveillance system that integrates 
population-based and institution-based data sources. An 
integrated  strategy  that  bridges  and  links  USAPI  data 
sources can support evidence-based policy and population 
health interventions.
Introduction
Although chronic disease has long concerned high-income 
countries, 80% of chronic disease deaths occur in low- to 
middle-income countries (1). A complex interplay of socio-
economic,  demographic,  technologic,  cultural,  environ-
mental, and biological factors explains this epidemiologic 
transition  from  communicable  disease  to  noncommuni-
cable disease (NCD) (1,2). The burden of chronic disease is 
substantial in the US Associated Pacific Islands (USAPI) 
jurisdictions  (American  Samoa,  Guam,  Commonwealth 
of  the  Northern  Mariana  Islands  [CNMI],  Federated 
States  of  Micronesia  [FSM]  [Chuuk,  Kosrae,  Pohnpei, 
and Yap], Republic of Palau, and Republic of the Marshall 
Islands [RMI]). For example, although differences in age- 
standardizations hinder comparison (3,4), age-standard-
ized  cardiovascular  disease  (CVD)  mortality  estimates 
among the USAPI jurisdictions are generally higher than 
similar  US  age-standardized  CVD  mortality  estimates 
(5,6) (Table 1).
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The USAPI jurisdictions’ population spreads across 104 
inhabited  islands  in  more  than  3  million  square  miles 
of  ocean,  crossing  the  International  Date  Line.  Despite 
the challenges of geographic isolation, dependence on US 
and  international  aid,  and  lack  of  health  care  funding 
(7), the USAPI jurisdictions are targeting chronic disease 
prevention  by  developing  partnerships  and  approaches 
that  reflect  the  interface  between  Pacific  cultures  and 
Western science (2,8,9). In addition, a May 2010 Pacific 
Island Health Officers Association resolution declaring a 
state of health emergency due to the epidemic of chronic 
disease encourages stronger coordination of partnerships 
across  multiple  sectors  to  mobilize  policy,  investments, 
and technical resources to reduce the prevalence and costs 
of chronic disease within the region (10). Effective chronic 
disease surveillance systems can support this effort and 
help the USAPI leadership monitor disease trends, evalu-
ate public policy, prioritize resource allocations, and guide 
program planning, evaluation, and research.
Surveillance is defined as the ongoing, systematic collec-
tion, analysis, interpretation, and dissemination of data 
essential  for  health  promotion  and  disease  prevention 
(11). Chronic disease surveillance data sources supported 
by the Centers for Disease Control and Prevention (CDC), 
World  Health  Organization  (WHO),  and  USAPI  health 
care  systems  can  be  divided  into  2  main  categories:   
population-based (ie, household surveys) and institution-
based (ie, disease registries) (Figure). The objective of this 
study was to assess the quality of existing USAPI chronic 
disease data sources and identify the capacity for chronic 
disease surveillance by individual jurisdiction, following 
WHO’s Health Metric Network Framework (HMNF). We 
also offer recommendations for continued capacity build-
ing to strengthen surveillance within the region.
Methods
After reviewing the literature and documents available on 
the web or through individual jurisdictions, we established 
an  inventory  of  data  sources  for  monitoring  standard   
chronic  disease  indicators  (11).  Using  this  list,  USAPI 
chronic  disease  representatives  identified  their  jurisdic-
tions’ existing data sources, frequency of data collection, 
and availability of analysis and reporting. For each identi-
fied data source, the frequency of data collection, analysis, 
and  reporting  was  confirmed  by  the  respective  USAPI 
Ministry of Health or Department of Health administra-
tion. CDC verified USAPI participation in the CDC-sup-
ported data sources. The US Renal Data System (USRDS) 
Western  Pacific  Renal  Network  verified  the  Medicare 
certification  dates  for  jurisdictions  participating  in  the 
USRDS  data  network  (S.  Tanner,  oral  communication, 
April 2011).
We completed a literature search concerning USAPI capac-
ity for chronic disease surveillance through the National 
Library of Medicine’s and National Institutes of Health’s 
PubMed  (www.ncbi.nlm.nih.gov/pubmed/)  and  EBSCO’s 
Cumulative Index to Nursing and Allied Health Literature 
(CINAHL). Publications included meet the following crite-
ria: 1) they assessed chronic disease surveillance capacity 
for the USAPI region overall or by individual jurisdiction 
and 2) were published in English within the last 10 years 
(ie, 1999 through October 2010). We excluded publications 
that presented only results of USAPI chronic disease-relat-
ed research (ie, epidemiologic, clinical, and qualitative) or 
program  evaluation  without  inclusion  of  an  assessment 
related to chronic disease surveillance in the region overall 
or by individual jurisdiction. Search terms were “chronic 
disease,” “population surveillance,” “disease surveillance,” 
“American  Samoa,”  “Guam/epidemiology,”  “Micronesia/
epidemiology,” and “Marshall Islands.” To select the publi-
cations, the titles and abstracts were reviewed by 1 author 
(G.H.) for relevance; those that met the inclusion criteria 
were  selected.  Subsequently,  the  entire  text  of  selected 
publications was read and publications that did not meet 
the inclusion criteria were excluded.
We used the WHO HMNF as the foundation for assessing 
the  quality  of  USAPI  chronic  disease  surveillance  data 
sources  and  identifying  jurisdiction  capacity  (Table  2). 
The HMNF is a global health partnership formed in 2005 
Figure. Potential chronic disease surveillance data sources. Chronic disease 
surveillance may include both population-based and institution-based data 
sources. Population-based sources include census data, vital records, and 
population health surveys. Institution-based sources include administrative 
records (eg, tax revenues), health service records (eg, occupational health), 
and health system records (eg, disease registries).  
Adapted from Health Metrics Network Framework (http://www.who.int/
healthmetrics/documents/hmn_framework200803.pdf). VOLUME 8: NO. 4
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that supports assessment and capacity building for health 
information systems in low- to middle-income countries 
(12).  Two  authors  (G.H.,  H.I.)  completed  independent 
assessments for each data source by using supporting doc-
umentation retrieved from web-based archives, literature 
review, or from surveillance documentation provided by 
individual jurisdictions. Aggregate scores for each assess-
ment criterion ranged from 3 (highly adequate) to zero (not 
adequate). We did not score data sources without complete 
documentation.
Results
USAPI data sources are listed by category and data avail-
ability by year (Table 3). A summary description of each 
data source follows.
Population-based data sources
The Behavioral Risk Factor Surveillance System (BRFSS) 
is  a  standardized  survey  that  includes  measures  for 
chronic  disease  risk  factors  and  conditions,  preventive 
health practices, and access to health care among adults 
(≥18 y) (www.cdc.gov/brfss/index.htm). The BRFSS uses 
a computer-assisted telephone-interviewing system with 
participation  limited  to  households  with  available  tele-
phone service. 
The  WHO  STEPwise  approach  (STEPS)  is  a  standard-
ized  population  health  survey  of  adults  aged  25  to  64 
years that measures chronic disease and associated risk 
factors. STEPS involves a 3-step sequential process: 1) a 
questionnaire assessing demographic, behavioral, and life-
style risks; 2) direct anthropometrical and blood pressure 
measures; and 3) biochemical assessment of blood samples 
(www.who.int/chp/steps/en). 
The Youth Risk Behavior Surveillance System (YRBSS) is 
a standardized national school-based surveillance system 
that surveys students in grades 9 through 12 to measure 
behaviors  that  contribute  to  unintentional  injuries  and 
violence; tobacco use; alcohol and drug use; unintended 
pregnancy and sexually transmitted diseases; unhealthy 
dietary  behaviors;  and  physical  inactivity.  Participating 
USAPI jurisdictions conduct the survey every 2 to 4 years 
(www.cdc.gov/yrbss).
The Youth Tobacco Survey (YTS) is a standardized school-
based  survey  that  provides  data  necessary  to  support 
the  design,  implementation,  and  evaluation  of  tobacco 
prevention and control programs for students in middle 
(grades 6-8) and high (grades 9-12) schools. The similar 
Global Youth Tobacco Survey (GYTS) is a standardized 
school-based survey (students aged 13-15 years) designed 
to build global capacity to monitor youth tobacco use, guide 
implementation and evaluation of tobacco prevention and 
control programs, and compare tobacco use data (www.
cdc.gov/tobacco/index.htm). USAPI jurisdictions generally 
participate in the YTS every 4 to 5 years. Each USAPI 
jurisdiction may conduct the YTS or the GYTS.
Institution-based data sources
Disease registries
Cancer.  Each  jurisdiction  collects  data  on  cancer  inci-
dence, types, and sites and extent of cancer at diagnosis. 
USAPI jurisdictions submit their cancer data to the Pacific 
Regional  Central  Cancer  Registry,  which  compiles  and 
reports them to CDC as de-identified cancer information 
(www.cdc.gov/cancer/npcr).
Renal disease. USRDS is a national data system that 
collects, analyzes, and distributes information about end-
stage renal disease in the United States (www.usrds.org). 
Medicare-certified dialysis centers operating in the USAPI 
contribute data to USRDS. Guam has 4 certified facilities 
submitting data; American Samoa has 1 certified facility 
and the CNMI has 2 certified facilities. The USRDS does 
not include FSM, Palau, or RMI (because of federal com-
pact agreements).
Health system records
Vital statistics include data on births and deaths (includ-
ing  fetal  deaths).  For  chronic  disease  surveillance,   
mortality data are used to track underlying and contrib-
uting cause of death and life expectancy. Using standard 
forms and procedures (ie, International Classification of 
Diseases, 10th revision [ICD-10] codes to classify deaths), 
the National Vital Statistics System (NVSS) within the 
National Center for Health Statistics estimates mortality 
rates for American Samoa, CNMI, and Guam (5). Mortality 
estimates for FSM, Palau, and RMI are available through 
WHO (6) or individual jurisdictions.
Hospital  discharge  data  are  abstracted  records  docu-
menting  an  individual’s  hospital  stay.  These  records 
include information on patient demographics, diagnosis,   VOLUME 8: NO. 4
JULY 2011
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treatment,  and  discharge  condition.  Individual  jurisdic-
tions collect, analyze, and report hospital discharge data.
Literature review data sources
The  MEDLINE  and  CINAHL  database  search  found 
no  published  reports  regarding  assessment  of  chronic 
disease  surveillance  capacity  within  the  USAPI  region 
overall. Haddock (13) provided a historical perspective of 
Guam’s communicable disease, vital statistics, cancer, and   
maternal-child health surveillance. Most published reports 
were specific to assessment of the USAPI’s capacity for 
cancer  control  and  prevention  (including  surveillance), 
summarized by Tsark and Braun (14) and published in 
Pacific Health Dialog (15).
Assessment of USAPI data sources
The following summarizes data source assessments (Table 
4).
Content and scope
In general, the quality of data source content was rated 
as  highly  adequate;  most  jurisdictions  reported   par-
ticipation in standardized population-based surveys (ie, 
BRFSS, YRBSS, GYTS, YTS, or STEPS). Jurisdictions 
also reported continual administration of vital records, 
disease registries (eg, cancer, USRDS), and other health 
system  records  (eg,  hospital  discharge).  Collectively, 
these data sources provide most jurisdictions with uni-
form measures for cancer, CVD, diabetes, tobacco and 
alcohol  use,  physical  activity  and  nutrition,  other  dis-
eases and risk factors, demographics, and socioeconomic 
conditions.
Data  collection  frequency  and  the  availability  of  a 
nationally representative population-based sample vary 
among  jurisdictions.  For  example,  the  annual  Guam 
BRFSS uses a representative adult (≥18 y) population 
sample.  In  comparison,  STEPS  uses  a  sample  of  rep-
resentative  adults  (aged  25-64  y),  although  individual 
jurisdictions may adjust the age range of the target pop-
ulation. However, administration of the STEPS survey 
ranges from every 5 years in Pohnpei (2002 and 2007) 
to more than 5 years for American Samoa (2004) and 
RMI (2002). Finally, whereas representative data were 
consistently available for Palau’s YRBS, availability of 
representative YRBS data from other jurisdictions var-
ied by survey year.
Jurisdictional capacity
Generally, jurisdictional capacity is adequate; jurisdictions 
rely on US or WHO fiscal, administrative, and technical 
support for most data sources. Except for the STEPS sur-
vey, most USAPI population-based surveys have weighted 
data  available  by  subgroup  (ie,  age,  sex)  across  survey 
years. However, disaggregated analysis by socioeconomic 
status (ie, income, education, and occupation) is limited to 
selected measures within the Guam BRFSS. Availability 
of STEPS disaggregated analysis by socioeconomic status 
is unavailable for participating jurisdictions. 
Dissemination
Dissemination  of  metadata  and  microdata  files  varied 
across  data  sources.  For  example,  dissemination  of  the 
BRFSS,  YRBSS,  GYTS,  and  YTS  data  analysis  and 
reports  was  adequate,  supported  by  the  availability  of 
reports within 12 months of survey completion and meta-
data  accessible  through  CDC  websites.  Microdata  are 
available on request or through web-based data reposito-
ries. In comparison, dissemination of STEPS data analysis 
and reports range from present but not adequate (FSM 
and  RMI)  (16,17)  to  adequate  (American  Samoa)  (18). 
Although STEPS metadata and microdata are available 
through the STEPS website or on request, the timeliness 
of analysis and reporting varies across participating juris-
dictions.
For  USAPI  jurisdictions  participating  in  the  USRDS, 
annual reports and a web-based data repository are pub-
licly available. USAPI mortality estimates, supported by 
the  NVSS  and  WHO,  are  timely  (ie,  <4  y),  with  meta-
data and microdata available (5,6). USAPI jurisdictions 
generate hospital discharge reports that are available to 
jurisdiction health program administrators and planners, 
physicians, and others on request.
Additionally,  the  WHO  Western  Pacific  Office  and 
Secretariat of the Pacific Community (SPC) provide web-
based links to current country health profiles (19) and the 
Pacific Regional Information System databanks (20) for 
each USAPI jurisdiction. The WHO databanks, updated 
annually, contain mostly crude data supplied by jurisdic-
tions  or  compiled  from  national  surveys,  reports,  policy 
documents, and databases. The PRISM databank links to 
jurisdiction statistical websites and provides regional data 
tables. However, data availability, coverage, and reliability 
vary from jurisdiction to jurisdiction and for each reported VOLUME 8: NO. 4
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measure. For example, FSM and RMI are the sole juris-
dictions that link (PRISM) to detailed reports related to 
mortality and hospital discharge summaries (20).
Integration
Overall,  integration  of  available  surveillance  reports  by 
USAPI  chronic  disease  teams  was  rated  as  adequate 
across jurisdictions. For example, jurisdictions have used 
surveillance  reports  to  develop  a  multiyear  plan  (2009-
2013)  supported  by  CDC  for  the  integration  of  tobacco 
control  and  diabetes  prevention  and  control  programs, 
although the incorporation of available population-based 
data is generally more extensive than for institution-based 
chronic disease data sources. The USAPI are linking the 
multiyear plans for integrated tobacco control and diabe-
tes prevention and control with other NCD prevention ini-
tiatives to establish holistic approaches, decrease program 
overlap, and leverage resources within the islands.
CNMI, FSM, Palau, and RMI, with support from WHO 
and SPC, have developed national NCD plans (2008-2011), 
focused  on  reducing  behavioral  risk  factors  (eg,  tobacco 
and alcohol use, dietary behaviors, and physical inactiv-
ity). American Samoa and Guam began development of 
national NCD plans in 2010, linking a number of healthy 
lifestyle initiatives (eg, Live Healthy Guam) (21) and com-
prehensive  cancer  control  plans:  Guam  Comprehensive 
Cancer  Control  Plan  (2007-2012)  and  American  Samoa 
Cancer Prevention Plan (2001-2012) (9). Because most of 
the USAPI NCD multiyear plans were developed within 
the last 2 to 3 years, use of surveillance data in program 
evaluation was not assessed.
Discussion
Our  review  showed  that  the  USAPI  jurisdictions  are 
using  both  population-based  and  institution-based  data 
sources to build capacity for chronic disease surveillance. 
The USAPI chronic disease data sources are aligned with 
widely accepted indicators for chronic disease surveillance 
(11) that use standardized measures and methodology to 
collect, analyze, and report data related to chronic disease 
behavioral risk, preventive practices, illness, and death. 
Consistent use of these data sources allows the USAPI to 
establish population benchmarks, compare chronic disease 
trends  regionally  and  among  other  population  groups 
within the United States and internationally, set priorities 
for resource allocations, and guide evidence-based policy 
and  population  health  interventions  needed  for  chronic 
disease prevention.
However, the review also illustrated the need to strength-
en USAPI chronic disease surveillance through expanded 
support  for  valid  and  reliable  data  collection,  analysis, 
and reporting among population-based data sources. For 
example, 5 jurisdictions began monitoring and tracking 
health  risk  behaviors  among  youth  and  young  adults 
(YRBSS, YTS) in the early 1990s. Although these surveys 
are administered at standard intervals, statistical analy-
sis and reports are generated by CDC for participating 
jurisdictions that obtain an overall response rate of 60% or 
more and submit appropriate survey documentation. With 
the exception of Palau’s YRBSS, timely and reliable data 
collection representative of the target YRBSS youth and 
young adult population across survey years varies among 
participating jurisdictions. Similar challenges exist with 
obtaining representative samples every 4 to 5 years for the 
YTS and GYTS.
Additionally, Guam, through participation in BRFSS, is 
the sole jurisdiction with sustained capacity for monitor-
ing and tracking adult (≥18 y) health risk behavior and 
preventive  practices.  Other  jurisdictions  (eg,  Palau)  are 
building capacity for participation in BRFSS or STEPS 
(American Samoa, CNMI, FSM, and RMI), but financial 
resources and organizational capacity are limited. These 
constraints were particularly evident for STEPS, resulting 
in challenges with timeliness and consistency of survey 
administration (>5 y in American Samoa and RMI), data 
analysis (ie, standardized weighting and disaggregation by 
age, sex, and socioeconomic status), and reporting. USAPI 
jurisdictions’  chronic  disease  surveillance  infrastructure 
does  not  adequately  support  the  standard  and  complex 
analysis of STEPS and other available surveillance data.
Although jurisdictional institution-based chronic disease 
data sources use nationally accepted standards and meth-
odology,  data  quality  concerns  remain.  These  concerns 
are
• Timeliness of data collection, analysis, and reporting.
• Underreported vital statistics registration data. 
• Underreported diagnostic or mortality data for USAPI 
residents  who  receive  medical  treatment  in  the  US 
mainland. 
• Systematic biases in diagnosis by health care providers 
in islands or atolls with limited medical support.
• Health  record  system  issues  that  include  challenges VOLUME 8: NO. 4
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with broadband Internet access, lack of electronic medi-
cal record systems, lack of synthesis or analysis across 
multiple record systems, incorrect or incomplete death 
certificates, misinterpretation of ICD rules, and varia-
tions of coding categories for unknown and ill-defined 
diseases or cause of death (5,6,14).
Finally,  this  review  did  not  assess  biases  within   
population-based data sources. For instance, the YRBSS 
and YTS exclude youths not attending or registered within 
jurisdictional  school  systems.  The  BRFSS  includes  only 
households with an available landline telephone and uses 
self-reported data. Additionally, sample size in some sur-
vey modules may limit data analysis. Lastly, responders to 
population health surveys might not be representative of 
the total target population.
Conclusion
Chronic  disease  surveillance  can  provide  a  foundation 
for population health efforts designed to address health 
disparities within USAPI communities. Using the HMNF, 
this  assessment  provides  an  initial  platform  to  under-
stand  the  quality  of  existing  USAPI  data  sources  and 
identify  jurisdictional  capacity  for  chronic  disease  sur-
veillance. The need to strengthen USAPI chronic disease 
surveillance through continued assessment and expanded 
support  for  valid  and  reliable  data  collection,  analysis 
and  reporting,  dissemination,  and  integration  among   
population-based  and  institution-based  data  sources  is 
common  across  jurisdictions.  Continued  engagement  of 
USAPI  leadership  across  multiple  sectors  (eg,  public 
health, business, education, faith- and community-based 
groups) to empower innovative systems and linkages for 
chronic disease surveillance is essential for understanding 
and improving health within Pacific communities.
Our recommendations are aligned with the White House 
Initiative  on  Asian  Americans  and  Pacific  Islanders 
(www.whitehouse.gov/administration/eop/aapi)  and 
the  Department  of  Health  and  Human  Services  (HHS) 
National Partnership for Action to End Health Disparities 
(www.minorityhealth.hhs.gov/npa/)  designed  to  mobi-
lize  a  comprehensive,  community-driven,  and  sustained 
approach  to  reducing  health  disparities  among  racial 
and ethnic minorities. Recommendations include contin-
ued  assessment,  investment,  and  technical  assistance 
in support of a chronic disease surveillance system that 
integrates USAPI population-based and institution-based 
data sources. Innovative strategies that link and expand 
these  data  sources  could  advance  evidence-based  policy 
and  environmental  transformations  that  target  chronic 
disease  prevention.  Related  recommendations  include 
1)  collaboration  among  USAPI  governance,  local  and 
regional partnerships, and US and international agencies 
to  integrate  surveillance;  2)  investments  to  strengthen 
USAPI infrastructure that support an expanded surveil-
lance system; 3) workforce development, through educa-
tion and training, to promote quality surveillance; and 4) 
translation of data to inform policy, research, and program 
planning and evaluation at local, national, and interna-
tional levels.
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Tables
Table 1. Age-Adjusted Estimates of Cardiovascular Disease Death Rates per 100,000 Population in the United States and US 
Associated Pacific Islands
Location NCHS CVDa Death Rate Estimates 2007b WHO CVDa Death Rate Estimates 2004c
United States 233 19
American Samoa 32 NA 
Guam 28 NA 
CNMId 16 NA 
RMI NA 02
Palau NA 390
FSM NA 364
 
Sources: Xu et al () and World Health Organization Statistical Information Systems (6). 
Abbreviations: CVD, cardiovascular disease; NA, no estimate available; CNMI, Commonwealth of the Northern Mariana Islands; RMI, Republic of the Marshall 
Islands; Palau, Republic of Palau; FSM, Federated States of Micronesia. 
a CVD includes rheumatic, hypertensive, ischemic, cerebrovascular, inflammatory, and other forms of heart disease. 
b Age-standardized to the US population census per 100,000 population, 200. 
c Age-standardized by using WHO World Standard methodology per 100,000 population, 2004. 
d CVD estimate excludes cerebrovascular disease.VOLUME 8: NO. 4
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Table 2. Assessing Chronic Disease Surveillance Data Source Quality — Criterion, Definition, and Rating Scale 
Core Assessment 
Criterion Definition
Rating Scale
Highly adequate Adequate
Present But Not 
Adequate Not Adequate
3 2 1 0
Content and scope Content and scope includes 
1) standard chronic disease indicatorsa
2) representative population or reliable 
health record system or both
3) administration frequency ≤5 years
Meets all criteria Meets 2 criteria Meets 1 crite-
rion
Frequency >6 years
Jurisdiction capacity Capacity for 
1) survey administration: sample design and 
field work; data processing; and analysis 
and/or health recording by using ICD-10 
coding; data processing and analysis
2) disaggregated analysis by age, sex, locale
3) disaggregated analysis by socioeconomic 
position: education and income (as appropri-
ate)
4) follows standards for consent, confidenti-
ality, and data access protection
Capacity for all 
criteria
Capacity for 3 
criteria
Capacity for 1-2 
criteria
No evidence
Dissemination Availability of 
1) summary reports within 1-4 years after 
completion of survey or health record data 
collection
2) metadatab publicly available
3) microdatac available
Availability of all 
criteria
Availability of 2 
criteria
Availability of 1 
criterion
No evidence
Integration Jurisdiction chronic disease team: 
1) uses available data reports to support an 
integrated multiyear chronic disease preven-
tion plan
2) works across chronic disease programs 
to coordinate and strengthen surveillance 
efforts
3) uses surveillance data for program plan-
ning and evaluation
Meets all criteria Meets 2 criteria Meets 1 crite-
rion
No evidence
 
Source: World Health Organization (12). 
Abbreviation: ICD-10, International Classification of Diseases, 10th revision. 
a Chronic disease indicators are divided into 8 categories, representing chronic disease conditions, risk factors, and social context: cancer, cardiovascular 
disease, diabetes, arthritis, tobacco and alcohol use, physical activity and nutrition, other diseases and risk factors, and overarching conditions (eg, socioeco-
nomic, life expectancy, and health insurance). Centers for Disease Control and Prevention, 2004 (11). 
b Metadata is defined as structured information that describes, locates, and helps retrieve data resource (includes design, sampling methodology, and ques-
tionnaires). 
c Microdata is defined as survey data set (results).VOLUME 8: NO. 4
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Table 3. Chronic Disease Surveillance Sources and Availability, US Associated Pacific Islands
Core Assessment 
Criterion
American 
Samoa CNMI
FSM
Guam
Republic of 
Palau RMI Chuuk Kosrae Pohnpei Yap
Population-baseda
BRFSS
Availability by year NA 2009b NA NA NA NA 2001-2003; 
200-2011
2009c NA
WHO STEPS
Availability by year 2004 2010d 200e 2009e 2002, 
200e
2009e NA NA 2002
YRBSS
Availability by year 1993, 199, 
1999, 200
2003, 200, 
200, 2009
NA NA NA NA 199, 199, 
2001, 200
1999, 2001, 
2003, 200, 
200, 2009
2003, 200, 
2009
YTS
Availability by year 200 2000, 2004 2000 2000 2000 NA 2002 2000, 200, 
2009
NA
GYTS
Availability by year 2010d 2010d 200f 200f 200f 200f NA NA 2009
Institution-based
Disease registries
Cancer Registry
Availability by year 200- 
ongoing
200- 
ongoing
200f-
ongoing
200f-
ongoing
200f-
ongoing
200f-
ongoing
200- 
ongoing
1999- 
ongoing
200- 
ongoing
US Renal Data System (USRDS)
Availability by year 1982-ongo-
ing
1983-ongo-
ing
NA NA NA NA 19-ongo-
ing
NA NA
Health record data systems
Vital Statistics
Availability Ongoing Ongoing Ongoingf Ongoingf Ongoingf Ongoingf Ongoing Ongoing Ongoing
Hospital Discharge
Availability Ongoing Ongoing Ongoingf Ongoingf Ongoingf Ongoingf Ongoing Ongoing Ongoing
 
Abbreviations: CNMI, Commonwealth of the Northern Mariana Islands; FSM, Federated States of Micronesia; RMI, Republic of the Marshall Islands, BRFSS, 
Behavioral Risk Factor Surveillance System; NA, not applicable; WHO STEPS, World Health Organization STEPwise Approach; YRBSS, Youth Risk Behavior 
Surveillance System; YTS, Youth Tobacco Survey; GYTS, Global Youth Tobacco Survey.  
a Weighted data available unless otherwise indicated. 
b Independent administration of cross-sectional household interview using BRFSS questionnaire supported through CNMI Department of Public Health. 
c Standardized BRFSS point-in-time survey. 
d Anticipates completion of data collection in 2011. 
e Unweighted data only. 
f Participates under FSM National Health Statistics Office.VOLUME 8: NO. 4
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Table 4. Summary of USAPI Chronic Disease Surveillance Data Source Quality by Jurisdictiona
Data Source
American 
Samoa CNMI
FSM
Guam
Republic of 
Palau RMI Chuuk Kosrae Pohnpei Yap
BRFSS
Content/scope
NS NAb NS
3
NAc NS
Jurisdiction capacity 3
Dissemination 3
Integration 2
WHO STEPS
Content/scope 0
NAd NAe NAe
3f
NAe NS NS
0
Jurisdiction capacity 2 2f 2
Dissemination 3 2f 2
Integration 3 3f 3
YRBSS
Content/scope 2 2
NS
2 3 2
Jurisdiction capacity 3 3 3 3 3
Dissemination 3 3 3 3 3
Integration 2 2 2 2 2
GYTS or YTS
Content/scope 2 2 2 0 3 2
Jurisdiction capacity 2 2 2 2 2 2
Dissemination 2 2 2 2 2 2
Integration 2 2 2 2 2 2
Cancer registry
Content/scope 3 3 3 3 3 3
Jurisdiction capacity
NAg NAg NAg NAg NAg NAg Dissemination
Integration
 
Abbreviations: CNMI, Commonwealth of the Northern Mariana Islands; FSM, Federated States of Micronesia; RMI, Republic of the Marshall Islands; 
BRFSS, Behavioral Risk Factor Surveillance System; NS, no survey was conducted; NA, not assessed; WHO STEPS, World Health Organization STEPwise 
Approach; YRBSS, Youth Risk Behavior Surveillance System; GYTS, Global Youth Tobacco Survey; YTS, Youth Tobacco Survey. 
a Key: 3, highly adequate; 2, adequate; 1, present but not adequate; 0, not adequate.  
b Independent administration of BRFSS questionnaire in 2009; data analysis and reporting in process; assessment not completed. 
c BRFSS point-in-time survey; data analysis and reporting not available; assessment not completed. 
d Anticipates STEPS data collection completion in 2011; assessment not completed.  
e STEPS data analysis and reporting not available; assessment not completed. 
f Assessment includes Pohnpei STEPS 2002 only; 200 Pohnpei STEPS data analysis and reporting not available; assessment not completed. 
g Reports not available; assessment not completed.
(Continued on next page)VOLUME 8: NO. 4
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Data Source
American 
Samoa CNMI
FSM
Guam
Republic of 
Palau RMI Chuuk Kosrae Pohnpei Yap
US Renal Data System (USRDS)
Content/scope 3 3
NS
3
NS NS
Jurisdiction capacity 2 2 2
Dissemination 2 2 2
Integration 1 1 1
Vital statistics
Content/scope 2 2 2 2 2 2
Jurisdiction capacity 2 2 2 2 2 2
Dissemination 2 2 2 2 2 2
Integration 1 1 1 1 1 1
Hospital discharge
Content/scope
NAg
2 2 2 2 2
Jurisdiction capacity 2 2 2 2 2
Dissemination 1 1 1 1 1
Integration 1 1 1 1 1
 
Abbreviations: CNMI, Commonwealth of the Northern Mariana Islands; FSM, Federated States of Micronesia; RMI, Republic of the Marshall Islands; 
BRFSS, Behavioral Risk Factor Surveillance System; NS, no survey was conducted; NA, not assessed; WHO STEPS, World Health Organization STEPwise 
Approach; YRBSS, Youth Risk Behavior Surveillance System; GYTS, Global Youth Tobacco Survey; YTS, Youth Tobacco Survey. 
a Key: 3, highly adequate; 2, adequate; 1, present but not adequate; 0, not adequate.  
b Independent administration of BRFSS questionnaire in 2009; data analysis and reporting in process; assessment not completed. 
c BRFSS point-in-time survey; data analysis and reporting not available; assessment not completed. 
d Anticipates STEPS data collection completion in 2011; assessment not completed.  
e STEPS data analysis and reporting not available; assessment not completed. 
f Assessment includes Pohnpei STEPS 2002 only; 200 Pohnpei STEPS data analysis and reporting not available; assessment not completed. 
g Reports not available; assessment not completed.
Table 4. (continued) Summary of USAPI Chronic Disease Surveillance Data Source Quality by Jurisdictiona